Randomized trial of coordinated psychosocial interventions based on patient self-assessments versus standard care to improve the psychosocial functioning of patients with cancer.

PURPOSE To determine whether making patient-reported cancer needs, quality-of-life (QOL), and psychosocial information available to the health care team, allowing coordinated specifically targeted psychosocial interventions, resulted in reduced cancer needs, improved QOL, and increased satisfaction with care received. METHODS Self-reported cancer needs, QOL, and psychosocial information was collected from 450 people with cancer, using standardized questionnaires via a touch-screen computer. For a randomly chosen two thirds, this information was made available to the health care team who coordinated targeted psychosocial interventions. Information from the remaining one third was not seen. Patients were assessed 2 and 6 months after randomization for changes in their cancer needs, QOL, and psychosocial functioning and satisfaction with overall care received. RESULTS There were no significant differences between the two arms with respect to changes in cancer needs, QOL, or psychosocial functioning between the baseline and follow-up assessments, nor with respect to satisfaction with care. However, for the subgroup of patients who were moderately or severely depressed at baseline, there was a significant reduction in depression for the intervention arm relative to the control arm at the 6-month assessment (P =.001). CONCLUSION Making patient-reported cancer needs, QOL, and psychosocial data available to the health care team at a single consultation together with coordinated psychosocial interventions does not seem to reduce cancer needs nor improve QOL, psychosocial functioning, or satisfaction with the care received. However, identification of patients with moderate or severe levels of depression may be valuable in reducing subsequent levels of depression.

[1]  L. Carlson,et al.  Impact of computerized quality of life screening on physician behaviour and patient satisfaction in lung cancer outpatients , 2000, Psycho-oncology.

[2]  G. Lattimore-Foot Needs assessment in tertiary and secondary oncology practice: a conceptual and methodological exposition , 1996 .

[3]  G. Goldsmith,et al.  Assessing the functional status of older patients with chronic illness. , 1989, Family medicine.

[4]  A. Stewart,et al.  Assessment of function in routine clinical practice: description of the COOP Chart method and preliminary findings. , 1987, Journal of chronic diseases.

[5]  A. Beck,et al.  Screening depressed patients in family practice. A rapid technic. , 1972, Postgraduate medicine.

[6]  John Stewart,et al.  Are touchscreen computer surveys acceptable to medical oncology patients , 1997 .

[7]  P S Kurtin,et al.  Monitoring dialysis patients' health status. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  D. Osoba,et al.  Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  P Ley,et al.  Satisfaction, compliance and communication. , 1982, The British journal of clinical psychology.

[10]  L. Fallowfield,et al.  Can oncologists detect distress in their out-patients and how satisfied are they with their performance during bad news consultations? , 1994, British Journal of Cancer.

[11]  J. Gould A Psychometric Investigation of the Standard and Short Form Beck Depression Inventory , 1982, Journal of consulting and clinical psychology.

[12]  I. Minas,et al.  The Prevalence of Psychiatric Morbidity in General Hospital Inpatients , 1991, The Australian and New Zealand journal of psychiatry.

[13]  R. Frankel,et al.  The effect of physician behavior on the collection of data. , 1984, Annals of internal medicine.

[14]  P. Fayers,et al.  Using reference data on quality of life--the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). , 1998, European journal of cancer.

[15]  E. Faragher,et al.  The ability of trainee general practitioners to identify psychological distress among their patients , 1993, Psychological Medicine.

[16]  D. Lerner,et al.  Physicians' assessment of functional health status and well-being. The patient's perspective. , 1995, Archives of internal medicine.

[17]  P Maguire,et al.  Helping cancer patients disclose their concerns. , 1996, European journal of cancer.

[18]  P Maguire,et al.  The recognition of psychiatric morbidity on a medical oncology ward. , 1989, Journal of psychosomatic research.

[19]  N K Aaronson,et al.  Quality of life assessment in daily clinical oncology practice: a feasibility study. , 1998, European journal of cancer.

[20]  N. Aaronson,et al.  Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses , 1999, British Journal of Cancer.

[21]  M. Atkinson,et al.  Computerized quality-of-life screening in an oncology clinic. , 1997, Cancer practice.

[22]  D. Forman,et al.  Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Tattersall,et al.  Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. , 1987, The New England journal of medicine.

[24]  W. Gregory,et al.  Who should measure quality of life, the doctor or the patient? , 1988, British Journal of Cancer.

[25]  R. Sanson-Fisher,et al.  The unmet supportive care needs of patients with cancer , 2000, Cancer.

[26]  L E Kazis,et al.  Health status reports in the care of patients with rheumatoid arthritis. , 1990, Journal of clinical epidemiology.

[27]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.